DE69133340D1 - Neue type-i-interferon varianten, ihre verfahren zur herstellung, und ihre verwendungen - Google Patents
Neue type-i-interferon varianten, ihre verfahren zur herstellung, und ihre verwendungenInfo
- Publication number
- DE69133340D1 DE69133340D1 DE69133340T DE69133340T DE69133340D1 DE 69133340 D1 DE69133340 D1 DE 69133340D1 DE 69133340 T DE69133340 T DE 69133340T DE 69133340 T DE69133340 T DE 69133340T DE 69133340 D1 DE69133340 D1 DE 69133340D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- interferon
- versions
- production process
- new type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9014945A FR2669931B1 (fr) | 1990-11-29 | 1990-11-29 | Nouveaux variants derives des interferons-alpha et leur procede de production. |
FR9014946A FR2669824B1 (fr) | 1990-11-29 | 1990-11-29 | Utilisation de variants des interferons alpha pour l'obtention de medicaments. |
PCT/FR1991/000953 WO1992009691A1 (fr) | 1990-11-29 | 1991-11-29 | Nouveaux variants derives des interferons de type i, leur procede de production, et leurs applications |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69133340D1 true DE69133340D1 (de) | 2003-12-18 |
Family
ID=26228360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69133340T Expired - Lifetime DE69133340D1 (de) | 1990-11-29 | 1991-11-29 | Neue type-i-interferon varianten, ihre verfahren zur herstellung, und ihre verwendungen |
Country Status (8)
Country | Link |
---|---|
US (1) | US5378823A (de) |
EP (1) | EP0513336B1 (de) |
JP (1) | JP3366947B2 (de) |
AT (1) | ATE254179T1 (de) |
AU (1) | AU656353B2 (de) |
CA (1) | CA2074802A1 (de) |
DE (1) | DE69133340D1 (de) |
WO (1) | WO1992009691A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
EP1274720A4 (de) | 2000-04-12 | 2004-08-18 | Human Genome Sciences Inc | Albumin enthaltende fusionsproteine |
US20080194481A1 (en) * | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
KR101271635B1 (ko) * | 2001-12-21 | 2013-06-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 알부민 융합 단백질 |
AU2005209926B2 (en) | 2004-02-02 | 2007-09-06 | Ambrx, Inc. | Modified human four helical bundle polypeptides and their uses |
EP2046367A4 (de) | 2006-06-07 | 2009-11-11 | Human Genome Sciences Inc | Albuminfusionsproteine |
CN101939443B (zh) | 2008-02-08 | 2014-01-29 | Ambrx公司 | 经修饰瘦素多肽和其用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4775622A (en) * | 1982-03-08 | 1988-10-04 | Genentech, Inc. | Expression, processing and secretion of heterologous protein by yeast |
CA1217440A (en) * | 1982-08-18 | 1987-02-03 | Michael A. Innis | INTERFERON .alpha. 6L |
NZ207926A (en) * | 1983-04-25 | 1988-04-29 | Genentech Inc | Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast |
PT83613B (en) * | 1985-10-28 | 1988-11-21 | Lilly Co Eli | Process for the selective chemical removal of a protein amino-terminal residue |
US4782139A (en) * | 1985-10-28 | 1988-11-01 | Eli Lilly And Company | Selective chemical removal of a protein amino-terminal residue |
DE3730331A1 (de) * | 1987-09-10 | 1989-03-30 | Basf Ag | Neue polypeptide, verfahren zur herstellung, die vektoren dafuer und arzneimittel daraus |
EP0400083A1 (de) * | 1988-03-18 | 1990-12-05 | Institut National De La Recherche Agronomique (Inra) | Trophoblastin-isoformen, durch diese isoformen konstituierte interferone, verfahren zu deren erhalt und deren verwendung |
WO1990009806A2 (en) * | 1989-03-02 | 1990-09-07 | University Of Florida | Composition for the inhibition of tumors and for the non-cytotoxic inhibition of replication of viruses |
FR2646437B1 (fr) * | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
-
1991
- 1991-11-29 JP JP50250392A patent/JP3366947B2/ja not_active Expired - Fee Related
- 1991-11-29 US US07/915,707 patent/US5378823A/en not_active Expired - Lifetime
- 1991-11-29 AU AU91305/91A patent/AU656353B2/en not_active Ceased
- 1991-11-29 DE DE69133340T patent/DE69133340D1/de not_active Expired - Lifetime
- 1991-11-29 CA CA002074802A patent/CA2074802A1/fr not_active Abandoned
- 1991-11-29 WO PCT/FR1991/000953 patent/WO1992009691A1/fr active IP Right Grant
- 1991-11-29 AT AT92902218T patent/ATE254179T1/de not_active IP Right Cessation
- 1991-11-29 EP EP92902218A patent/EP0513336B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH05504069A (ja) | 1993-07-01 |
JP3366947B2 (ja) | 2003-01-14 |
EP0513336A1 (de) | 1992-11-19 |
WO1992009691A1 (fr) | 1992-06-11 |
US5378823A (en) | 1995-01-03 |
ATE254179T1 (de) | 2003-11-15 |
CA2074802A1 (fr) | 1992-05-30 |
AU656353B2 (en) | 1995-02-02 |
EP0513336B1 (de) | 2003-11-12 |
AU9130591A (en) | 1992-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69634726D1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
ATE81779T1 (de) | Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren. | |
ATE80660T1 (de) | Verfahren zur herstellung eines polypeptides. | |
ATE402957T1 (de) | Analoge des menschlichen interferon-alpha mit niedriger toxizität | |
PL312436A1 (en) | Dna structural element encoding yap3 signal peptide | |
ATE174382T1 (de) | Retrovirus aus der hiv-gruppe und dessen verwendung | |
DE3583824D1 (de) | Vorlaeufer des insulins, verfahren zu seiner herstellung und verfahren zur herstellung von humaninsulin aus solchen vorlaeufern des insulins. | |
DK0477971T3 (da) | Humant CNP gen og precursorprotein | |
DE59101889D1 (de) | Variante cd44-oberflächenproteine, diese kodierende dna-sequenzen, antikörper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie. | |
ATE149523T1 (de) | Verfahren zur herstellung von interferon-alpha-2 kristallen | |
ATE339878T1 (de) | Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung | |
DE69133340D1 (de) | Neue type-i-interferon varianten, ihre verfahren zur herstellung, und ihre verwendungen | |
FI942442A0 (fi) | Proteiinien tuotto 7B2-proteiinia käyttäen | |
ATE141616T1 (de) | Neue peptide (didemnine), ihre herstellung und verwendung | |
FI940036A (fi) | Nukleotidisekvenssejä ja sykloheksimidiresistenssejä proteiineja | |
DE69106407T2 (de) | Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal. | |
ATE110779T1 (de) | Neue promotorregion. | |
ATE143974T1 (de) | Peptide des hiv-gag proteins, ihre herstellung und verwendung | |
ATE123056T1 (de) | Ancrod-proteine, ihre herstellung und verwendung. | |
NO974713D0 (no) | Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider | |
DE69534738D1 (de) | Leukocyten-aktivierender Faktor | |
ATE229983T1 (de) | Maspin- ein neues serpin mit tumor unterdrückender aktivität | |
ATE291629T1 (de) | Expressionssystem für die sekretion von bioaktivem, menschlichem granulozyt-makrophagem koloniestimulierungsfaktor (gm-csf) und anderen heterologen proteinen aus streptomyces | |
ATE110775T1 (de) | Verfahren zur herstellung von hirudin. | |
ATE86499T1 (de) | Vorbeugende massnahmen zur verhinderung der ''komplexen respiratorischen erkrankung bei rindern'' durch verabreichung von interferon. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |